Prognostic factors for breast cancer recurrence
作者： K.C. Aalders
DOI:
关键词:
摘要: Breast cancer is the most common type of in women worldwide. In Netherlands, over 14.000 a year are diagnosed with invasive breast cancer. Fortunately, prognosis patients improving thanks to increased insight tumor biology and continuing improvements systemic therapy. this thesis we evaluated rate recurrence as well associated prognostic factors. This knowledge can help us personalize treatment aim avoiding under treatment, thereby outcome reducing unnecessary toxicity.
参考文章(106)
Petri Salven, Athina Lymboussaki, Päivi Heikkilä, Hilkka Jääskela-Saari, Bernd Enholm, Karin Aase, Gabriel von Euler, Ulf Eriksson, Kari Alitalo, Heikki Joensuu, Vascular Endothelial Growth Factors VEGF-B and VEGF-C Are Expressed in Human Tumors The American Journal of Pathology. ,vol. 153, pp. 103- 108 ,(1998) , 10.1016/S0002-9440(10)65550-2
B Linderholm, B Tavelin, K Grankvist, R Henriksson, Does vascular endothelial growth factor (VEGF) predict local relapse and survival in radiotherapy-treated node-negative breast cancer? British Journal of Cancer. ,vol. 81, pp. 727- 732 ,(1999) , 10.1038/SJ.BJC.6690755
John E Park, Gilbert-A Keller, Napoleone Ferrara, None, The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Molecular Biology of the Cell. ,vol. 4, pp. 1317- 1326 ,(1993) , 10.1091/MBC.4.12.1317
Martin Barr, David Bouchier-Hayes, Judith Harmey, Vascular endothelial growth factor is an autocrine survival factor for breast tumour cells under hypoxia International Journal of Oncology. ,vol. 32, pp. 41- 48 ,(2008) , 10.3892/IJO.32.1.41
Yutaka Yamamoto, Mutsuko Ibusuki, Yasuhiro Okumura, Teru Kawasoe, Kazuharu Kai, Kenichi Iyama, Hirotaka Iwase, Hypoxia-inducible factor 1α is closely linked to an aggressive phenotype in breast cancer Breast Cancer Research and Treatment. ,vol. 110, pp. 465- 475 ,(2008) , 10.1007/S10549-007-9742-1
Richard M. Zuniga, Roy Torcuator, Rajan Jain, John Anderson, Thomas Doyle, Lonni Schultz, Tom Mikkelsen, Rebound tumour progression after the cessation of bevacizumab therapy in patients with recurrent high-grade glioma. Journal of Neuro-oncology. ,vol. 99, pp. 237- 242 ,(2010) , 10.1007/S11060-010-0121-0
Dimitrios Zardavas, José Baselga, Martine Piccart, Emerging targeted agents in metastatic breast cancer Nature Reviews Clinical Oncology. ,vol. 10, pp. 191- 210 ,(2013) , 10.1038/NRCLINONC.2013.29
D. Senger, S. Galli, A. Dvorak, C. Perruzzi, V. Harvey, H. Dvorak, Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science. ,vol. 219, pp. 983- 985 ,(1983) , 10.1126/SCIENCE.6823562
Kristy J. Gotink, Henk M. W. Verheul, Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action? Angiogenesis. ,vol. 13, pp. 1- 14 ,(2010) , 10.1007/S10456-009-9160-6
E.R. Horak, N. Klenk, R. Leek, S. LeJeune, K. Smith, N. Stuart, A.L. Harris, M. Greenall, K. Stepniewska, Angiogenesis, assessed by platelet/endothelial cell adhesion molecule antibodies, as indicator of node metastases and survival in breast cancer. The Lancet. ,vol. 340, pp. 1120- 1124 ,(1992) , 10.1016/0140-6736(92)93150-L